Some Rice University researchers have partnered with other institutions to continue bioelectrical implant treatment ...

An obesity expert weighs in on intriguing new data and new drugs that hold promise in the battle against a stubborn problem.

The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...

New-generation anti-obesity drug Wegovy, made by the same company that created Ozempic, is now available in France – but it ...

A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...

The pharmaceutical industry has seen a tremendous surge in the development of weight loss drugs, particularly GLP-1 receptor ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on ...

Now that Mounjaro has been authorised for use on the NHS, it will be key that access to specialist weight loss services is ...

Allowing Medicare to cover popular weight loss drugs such as Wegovy and Zepbound could increase federal spending by billions ...

While employers typically cover the medications for diabetes, fewer of them do so for weight loss, in part because of the ...